Your topics. New publications.

A compact browser notification when there’s something new. At most once a day — no account needed.

What interests you?

Optional and switchable off here at any time. We save your selected topics and device subscription; no email address is required. Privacy

Search the harborEN/DEAccount
mTOR & rapamycin
Video summary

Video description: rapamycin, mTOR and the human evidence

The description presents a plain-language series episode on mTOR as a growth switch, what rapamycin does, and the human evidence with its trade-offs; it gives no results. [1]

Automatic summary · not editorially reviewed

The key findings

  1. The description says the episode covers mTOR, described as a growth switch. [1]

  2. The description calls rapamycin the most promising longevity drug, with an asterisk. [1]

  3. The description labels the content educational only and not medical advice. [1]

The source at a glance

Study type / format
Video description of an educational series episode
Population / context
Viewers of a plain-language longevity video series; no study population is described.
Summary based on
Creator description
Original publication
July 20, 2026

mTOR as a growth switch in the series

According to the description, this episode of "The Science of Aging" covers mTOR, described as a growth switch. The series is presented as plain-language and no-hype, focused on longevity and on what the evidence actually shows. The description does not explain how mTOR works or what switching it means.

Supporting source [1]

Rapamycin and the human evidence with trade-offs

The description lists what rapamycin does and the human evidence and the trade-offs as topics of the episode. It calls the drug "the most promising longevity drug — with an asterisk", but gives no study, population, outcome or numbers. The description therefore does not show which human evidence or trade-offs are discussed.

Supporting source [1]

Educational framing of the rapamycin episode

The description labels the content educational only and not medical advice, and refers personal health decisions to a qualified medical professional. It also lists hashtags including longevity, aging, healthspan, antiaging, rapamycin, NAD, GLP1 and biohacking. These tags do not show that the episode covers NAD or GLP1.

Supporting source [1]

How to interpret this

Only the video description was available; the video and transcript were not reviewed. No studies, populations, outcomes or numbers are reported, so the described topics cannot be checked.

Based on the creator’s description; the full video and transcript were not analyzed.

Source & supporting passages

[1]
Rapamycin & mTOR — The Science of Aging (Ep. 5)

Life Sciences AI Applications · youtube.com · July 20, 2026

Read the quoted passagesIn the language of the original source
  1. Finding 1 ↑

    mTOR: the growth switch
  2. Finding 2 ↑

    The most promising longevity drug — with
  3. Finding 3 ↑

    Educational content only — this is NOT

AI-assisted summary with linked source passages. No independent editorial or clinical review.

Our editorial method

Discussion

Community discussions

0 topics

Member contributions. Share sources, disclose commercial interests, and avoid personal medical or dosing advice.

Loading…